SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-18-002211
Filing Date
2018-05-15
Accepted
2018-05-15 17:27:54
Documents
44
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_033118.htm 10-Q 490889
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 17544
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 16514
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 7248
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 7339
  Complete submission text file 0001387131-18-002211.txt   1976786

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20180331.xml EX-101.INS 221988
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20180331.xsd EX-101.SCH 20561
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20180331_cal.xml EX-101.CAL 33505
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20180331_def.xml EX-101.DEF 92575
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20180331_lab.xml EX-101.LAB 198811
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20180331_pre.xml EX-101.PRE 152382
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 18837965
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1